Upfront progression under pembrolizumab followed by a complete response after encorafenib and cetuximab treatment in
BRAF V600E
‐mutated and microsatellite unstable metastatic colorectal cancer patient: a case report
2018 ◽
Vol 9
(4)
◽
pp. E23-E27
◽
2019 ◽
Vol 10
(5)
◽
pp. 1010-1014
◽
2018 ◽
Vol 144
(10)
◽
pp. 2001-2010
◽
2019 ◽
Vol 5
◽
2016 ◽
Vol 22
(12)
◽
pp. 3067-3077
◽